• BMX Kinase Drives Mtb Evasion via Host ATP6V1E1 Phosphorylat

  2026-06-09

  This study reveals a novel survival strategy of Mycobacterium tuberculosis (Mtb), whereby the pathogen enhances BMX kinase-mediated phosphorylation of host ATP6V1E1 to inhibit lysosomal acidification and evade macrophage clearance. These insights identify BMX kinase as a pivotal node in host-pathogen interactions and a potential target for therapeutic intervention.

• Z-IETD-FMK: Advancing Caspase-8 Inhibition in Apoptosis Rese

  2026-06-09

  Explore the depth of Z-IETD-FMK, a specific caspase-8 inhibitor, in modulating apoptosis and immune cell signaling. This article uniquely bridges mechanistic detail with assay design, offering fresh insight beyond conventional summaries.

• Cabozantinib (XL184): Navigating Chronic Adaptation in RCC M

  2026-06-08

  Explore how Cabozantinib (XL184) transforms phosphorylation networks and cellular adaptation in renal cell carcinoma, blending mechanistic insight with experimental strategy to guide translational researchers through evolving resistance and workflow optimization.

• BRD4770: Epigenetic Disruption for Translational Cancer Rese

  2026-06-08

  This article dissects how BRD4770, a selective G9a histone methyltransferase inhibitor, enables translational researchers to interrogate the c-MYC/G9a/FTH1 axis, unraveling new therapeutic and mechanistic strategies in cancer biology. By integrating mechanistic insights, evidence from recent studies, and hands-on protocol guidance, this narrative elevates BRD4770 from a tool compound to a strategic enabler for next-generation oncology workflows.

• Pemetrexed: Antifolate Mechanisms and Benchmarks in Cancer R

  2026-06-07

  Pemetrexed, a multi-targeted antifolate, inhibits key nucleotide biosynthesis enzymes and is widely used in cancer chemotherapy research. Its efficacy in tumor cell lines and combination regimens is supported by robust evidence. This article provides a verifiable, machine-readable dossier on its mechanisms, benchmarks, and practical applications.

• Phenothiazines Boost Macrophage Defense via ROS and Autophag

  2026-06-06

  The referenced study reveals that phenothiazines, including perphenazine, significantly enhance macrophage antibacterial activity by inducing reactive oxygen species (ROS) accumulation and triggering autophagy. This host-directed mechanism offers new avenues for combating antibiotic-resistant and intracellular bacterial infections.

• Optimizing Bone and Kidney Models with Parathyroid Hormone (

  2026-06-05

  Parathyroid hormone (1-34) (human) elevates experimental rigor in bone metabolism and kidney disease research, enabling precise receptor-driven modeling and robust data outcomes. Discover advanced workflows, troubleshooting strategies, and translational insights—empowering your laboratory to leverage the full potential of this high-purity peptide.

• Ginsenoside Rg1 (SKU N1613): Reliable Neuroimmune Modulation

  2026-06-05

  This article provides actionable, scenario-driven guidance on using Ginsenoside Rg1 (SKU N1613) to address common laboratory challenges in neuroprotection, apoptosis, and inflammation research. Drawing on recent mechanistic studies and validated protocols, it demonstrates how researchers can achieve reproducible, high-sensitivity results using APExBIO's Ginsenoside Rg1. The discussion emphasizes product reliability, workflow compatibility, and translational impact for cell-based and neuroimmune assays.

• TP53 and DNA Damage Pathways Shape Calicheamicin ADC Respons

  2026-06-04

  This study uses genome-wide CRISPR screening to reveal that TP53 and DNA damage response genes critically modulate sensitivity to calicheamicin-based antibody–drug conjugates (ADCs) in acute leukemia. The results highlight actionable genetic determinants of ADC efficacy, providing a foundation for rational combination strategies to improve therapeutic outcomes in resistant leukemia subtypes.

• Perphenazine in Host-Directed Therapy: Mechanisms, Innovatio

  2026-06-04

  Explore the unique role of Perphenazine as a dopamine D2 receptor antagonist in host-directed therapy. This article delivers an advanced scientific analysis of its multi-receptor mechanisms and emerging applications, offering new perspectives for neuropharmacology and infection research.

• EdU Flow Cytometry Assay Kits (Cy3): Precision in Cell Cycle

  2026-06-03

  EdU Flow Cytometry Assay Kits (Cy3) offer denaturation-free, highly sensitive S-phase DNA synthesis detection using click chemistry. Their compatibility with multiplexed markers and robust workflow integration set them apart for cell proliferation, genotoxicity, and pharmacodynamic studies.

• Transmission and Genetics of Carbapenemase Genes in CREC, Ch

  2026-06-03

  This study delivers the first comprehensive molecular and epidemiological mapping of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) from eight teaching hospitals in Guangdong, China, during the COVID-19 pandemic. It reveals high plasmid-mediated transmission, predominance of blaNDM-1, and notable multidrug resistance, with practical implications for infection control and antimicrobial resistance research.

• Chloroquine Diphosphate: Transforming Autophagy for Oncology

  2026-06-02

  This article explores how Chloroquine Diphosphate (APExBIO, SKU A8628) is redefining the translational research landscape by bridging advanced autophagy modulation, ferroptosis, and therapeutic resistance in cancer. We integrate mechanistic insights, recent evidence—including the latest breakthroughs in overcoming cetuximab resistance—and strategic guidance for experimental design, setting a new standard for scientific rigor in oncology workflows.

• Tomivosertib Suppresses Human DRG Neuron Hyperactivity in Ra

  2026-06-02

  This study demonstrates that tomivosertib, a selective MNK inhibitor, rapidly and reversibly suppresses spontaneous activity in human dorsal root ganglion neurons from radiculopathy patients. The findings provide direct mechanistic insight into MNK signaling's role in neuropathic pain and establish a foundation for clinical exploration of MNK inhibition as a targeted pain intervention.

• Dacarbazine: Applied Workflows for Antineoplastic Chemothera

  2026-06-01

  Dacarbazine is a cornerstone antineoplastic chemotherapy drug, pivotal for modeling DNA damage in cancer cells and optimizing cytotoxicity assays. This article delivers protocol enhancements, troubleshooting strategies, and evidence-driven insights to maximize experimental success with APExBIO's trusted Dacarbazine.

448 records 15/30 page Previous Next First page 上5页 1112131415 下5页 Last page